| Scorecard |
|---|
|
4 / 5 Stars
|
|
Lipper
4
4
5
5
1
|
|
Zacks Investment Research
2
(Buy)
|
|
Standard & Poor's
3 / 5 Stars
|
|
TheStreet.com
C+
(Hold)
|
Fund Holdings
Asset Allocation
| % Long | % Short | % Net | |
|---|---|---|---|
| Cash | 17.0 | 15.14 | 1.86 |
| Stocks | 35.65 | 0.0 | 35.65 |
| Bonds | 0.0 | 0.0 | 0.0 |
| Other | 0.57 | 0.18 | 0.39 |
| Foreign Bonds | 0.0 | 0.0 | 0.0 |
| Foreign Stocks | 63.02 | 1.15 | 61.87 |
| Convertible | 0.0 | 0.0 | 0.0 |
| Preferred | 0.22 | 0.0 | 0.22 |
Updated 11.30.2012
Top 10 Holdings
Performance as of 04.30.2013
Portfolio as of 11.30.2012
| % Net Assets | |
|---|---|
| GMO US Flexible Equities VI | 38.25 |
| GMO International Core Equity VI | 21.59 |
| GMO Emerging Markets VI | 14.54 |
| GMO Intl Intrinsic Value IV | 12.19 |
| GMO Currency Hedged Intl Equity III | 6.91 |
| GMO US Core Equity VI | 3.43 |
| GMO Flexible Equities VI | 1.8 |
| GMO International Growth Equity IV | 1.3 |
| GMO Special Purpose Holding | 0.0 |
| GMO Special Purpose Holding Co | 0.0 |
